December 5th, 2014
Editor’s note: World AIDS Day, which is Monday, Dec. 1, serves as a reminder that while significant progress has been made in the global battle against HIV/AIDS, there is still much more to be done and we must recommit to the goal of Getting to Zero. Johnson & Johnson, driven by our purpose of caring, remains committed to the prevention, detection, education and treatment of HIV/AIDS. This blog post is the third in a series intended to provide a glimpse of these efforts and some of the individuals leading them.
I have been working in HIV for the greater part of three decades. Over this period, I have seen shifts in policy, advances in science, and starts and stops in action towards this disease. Every World AIDS Day, I take time to reflect upon the progress that has been made, and the work that remains to be done, both here in the U.S. and abroad, to better the lives of the millions of people living with HIV around the world.
There are over a million people living with HIV in the U.S. today. Less than 30 percent have reached their treatment goals.